Truvada: Recommended for pre-exposure prophylaxis (PrEP)

The United States FDA‘s advisory committee has recommended that Truvada should be approved for HIV prophylaxis. Gilead Sciences Inc is the manufacturer of the drug to be used in combination therapy of AIDS. The drug is a RTI (Reverse Transcriptase Inhibitor), although it can not destroy the virus but stops their replication. Truvada consists of … Read more

Bosutinib – Bosulif approved for Leukemia by Pfizer

A new anticancer drug for Leukemia has been approved by FDA. The drug treats chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects seniors.   It works by inhibiting the enzyme Tyrosine Kinase.